Science Explorer Interactive view Map
Company · Irving · United States

Reata Pharmaceuticals (United States)

reatapharma.comROR OpenAlex
Research works
100
▲ 97% vs 2013–17
Citations
3.2k
31.8 per fractional work
Top-10% rate
9.6%
record average 16.5%
Open access
47%
world 28%

Not ranked overall: Reata Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.11× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.38× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 1.59× its world share, 0 worksImmunology and Micro…Neuroscience: 1.26× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 10.00× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.49× its world share, 0 worksChemistryComputer Science: 0.59× its world share, 1 worksComputer ScienceEngineering: 0.13× its world share, 0 worksEngineeringEnvironmental Science: 0.36× its world share, 0 worksEnvironmental ScienceMathematics: 3.37× its world share, 1 worksMathematicsHealth Professions: 0.25× its world share, 0 worksHealth ProfessionsMedicine: 2.54× its world share, 12 worksMedicineEconomics, Econometrics and Finance: 5.22× its world share, 3 worksEconomics, Econometr…Psychology: 0.14× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.0×. Every wedge is a field page.

Who are the top researchers at Reata Pharmaceuticals (United States)?

Ranked on the composite score, Nicholas J. Robert lead among researchers whose main affiliation is Reata Pharmaceuticals (United States).

  1. 1 Nicholas J. Robert United States · #68,036 worldwide 225 citations · 44 works
All ranked researchers at Reata Pharmaceuticals (United States)

Which keywords describe research at Reata Pharmaceuticals (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Chemotherapy, Precision Medicine, Cancer, Clinical Trials, Biomarkers, Genomic Instability and Quality of Life.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 28 words, with their numbers
  1. Targeted Therapy3▲ 51×4 topics
  2. Chemotherapy3▲ 15×10 topics
  3. Precision Medicine3▲ 23×6 topics
  4. Cancer2▲ 6.9×10 topics
  5. Biomarkers2▲ 12×7 topics
  6. Clinical Trials2▲ 13×8 topics
  7. Quality of Life2▲ 5.7×4 topics
  8. Cancer Genomics2▲ 97×1 topic
  9. Genomic Instability2▲ 64×2 topics
  10. Inflammation2▲ 3.4×9 topics
  11. Mutational Signatures2▲ 97×1 topic
  12. Cost-effectiveness Analysis2▲ 78×1 topic
  13. Health Utility Measures2▲ 78×1 topic
  14. Predictive Modeling2▲ 24×2 topics
  15. Deep Learning2▲ 1.74×3 topics
  16. Healthcare2▲ 5.1×3 topics
  17. Antioxidant1▲ 7.9×3 topics
  18. Immunotherapy1▲ 7.5×9 topics
  19. Tumor Microenvironment1▲ 11×4 topics
  20. Cost of Care1▲ 152×1 topic
  21. Electronic Health Records1▲ 50×1 topic
  22. Financial Toxicity1▲ 152×1 topic
  23. Patient Similarity1▲ 82×1 topic
  24. Antiviral1▲ 55×2 topics
  25. Breast Cancer1▲ 19×5 topics
  26. Epidemiology1◆ 1.08×7 topics
  27. Medication Adherence1▲ 78×1 topic
  28. Treatment Adherence1▲ 157×1 topic

Which research topics does Reata Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Cancer Genomics and Diagnostics, Health Systems, Economic Evaluations, Quality of Life, Machine Learning in Healthcare and Economic and Financial Impacts of Cancer.

Cancer Genomics and Diagnostics: 2 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 2 fractional worksMachine Learning in Heal…1Machine Learning in Healthcare: 1 fractional worksEconomic and Financial I…1Economic and Financial Impacts of Cancer: 1 fractional worksMedication Adherence and Compliance: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksNatural product bioactiv…1Natural product bioactivities and synthesis: 1 fractional worksLung Cancer Treatments and Mutations: 1 fractional worksLung Cancer Diagnosis and Treatment: 0 fractional worksStatistical Methods in Clinical Trials: 0 fractional works
Cancer ResearchEconomics and EconometricsArtificial IntelligenceFamily Practice4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 2 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  3. 3 Machine Learning in Healthcare Artificial Intelligence 1 works
  4. 4 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  5. 5 Medication Adherence and Compliance Family Practice 1 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
  7. 7 Natural product bioactivities and synthesis Molecular Biology 1 works
  8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  9. 9 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  10. 10 Statistical Methods in Clinical Trials Statistics and Probability 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.3%not open52.7%

World: 28% of research is openly available.

with international co-authors19.3%domestic only80.7%

World: 19% is written across borders.

How has Reata Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 97% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Irving

All research institutions in Irving

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.